V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10448813 | 10034056 | 1.64 | 75.8 | null | 2019-03-24 | 2019-03-30 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101245337 |
| 10448826 | 10034057 | 1.87 | 76.5 | Neo-adjuvant (N) | null | 2018-06-23 | Rituximab | 02 | null | RITUXIMAB | 100577054 |
| 10448829 | 10034058 | 1.72 | 83.9 | Neo-adjuvant (N) | 2019-01-04 | 2019-01-04 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 100118408 |
| 10448877 | 10034059 | 1.66 | 76.2 | 03 | 2017-08-30 | 2017-09-05 | Capecitabine | 02 | null | CAPECITABINE | 100869511 |
| 10448895 | 10034060 | 1.57 | 65.5 | null | 2019-07-30 | 2019-08-09 | Capecitabine | 02 | null | CAPECITABINE | 100674720 |
| 10448898 | 10034061 | 1.8 | 73.6 | Adjuvant (A) | 2020-05-20 | 2020-06-18 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101002671 |
| 10448902 | 10034062 | 1.71 | 59.4 | Curative (C) | 2021-07-18 | 2021-08-15 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101595342 |
| 10448909 | 10034063 | null | 83.3 | Curative (C) | null | 2016-09-12 | Capecitabine | 02 | N | PEMBROLIZUMAB | 100965662 |
| 10448934 | 10034064 | 1.66 | 53 | Neo-adjuvant (N) | 2020-11-08 | 2020-11-11 | Capecitabine | 02 | null | CAPECITABINE | 101596419 |
| 10448945 | 10034065 | 1.63 | 60.5 | Adjuvant (A) | 2018-11-22 | 2018-11-26 | IBRUTINIB | 02 | null | IBRUTINIB | 100888674 |
| 10448979 | 10034066 | 0 | 68.6 | null | null | 2018-06-27 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100131393 |
| 10449024 | 10034067 | 1.63 | 81.2 | null | 2021-09-09 | 2021-09-12 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 101528575 |
| 10449025 | 10034068 | 1.58 | 54 | 03 | 2016-03-21 | 2016-03-21 | Rituximab | 02 | N | RITUXIMAB | 101468982 |
| 10449028 | 10034069 | 1.83 | 50 | Adjuvant (A) | 2017-10-13 | 2017-10-13 | IBRUTINIB | 02 | null | IBRUTINIB | 100555064 |
| 10449039 | 10034070 | 1.74 | 0 | Palliative (P) | 2017-01-14 | 2017-01-17 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100369936 |
| 10449040 | 10034071 | 1.71 | 63 | Disease modification (D) | 2022-03-10 | 2022-03-24 | CAPECITABINE + OXALIPLATIN | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101738248 |
| 10449079 | 10034072 | 1.57 | 64 | Adjuvant (A) | 2017-12-25 | 2017-12-29 | Rituximab | 2 | N | RITUXIMAB | 101504551 |
| 10449081 | 10034073 | 1.54 | 65.8 | 02 | 2020-08-21 | 2020-08-21 | IBRUTINIB | 02 | N | IBRUTINIB | 100554572 |
| 10449092 | 10034074 | 1.76 | 71 | Curative (C) | 2017-02-08 | 2017-02-08 | Capecitabine + Oxaliplatin 21day | 2 | N | CAPECITABINE + OXALIPLATIN | 101673533 |
| 10449117 | 10034075 | 1.52 | 80.9 | Palliative (P) | 2017-01-22 | 2017-01-22 | IBRUTINIB | 02 | null | IBRUTINIB | 101703500 |
| 10449131 | 10034076 | 1.75 | 94.7 | Curative (C) | 2017-08-24 | 2017-09-01 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101863503 |
| 10449144 | 10034077 | 1.55 | 62 | Palliative (P) | 2019-07-23 | 2019-07-25 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100463253 |
| 10449153 | 10034078 | 1.7 | 84.9 | Adjuvant (A) | 2019-10-28 | 2019-11-01 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100477728 |
| 10449161 | 10034079 | 1.52 | 61.2 | Neo-adjuvant (N) | null | 2016-02-28 | Rituximab | 02 | Y | RITUXIMAB | 100801735 |
| 10449164 | 10034080 | 1.58 | 46 | Curative (C) | 2017-05-27 | 2017-05-27 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100200894 |
| 10449166 | 10034081 | 1.85 | null | Palliative (P) | 2018-09-19 | 2018-09-27 | Capecitabine | 02 | N | CAPECITABINE | 100487228 |
| 10449169 | 10034082 | 1.92 | 88.4 | Adjuvant (A) | 2019-07-03 | 2020-02-19 | IBRUTINIB | N | N | IBRUTINIB | 101134809 |
| 10449170 | 10034083 | 1.84 | 64 | 03 | 2017-07-15 | 2017-07-19 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100150839 |
| 10449184 | 10034084 | 1.66 | 84.4 | 03 | 2020-08-29 | 2020-09-04 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100536195 |
| 10449216 | 10034085 | 1.77 | 73 | 03 | 2018-05-12 | 2018-05-24 | Capecitabine + Oxaliplatin 21day | N | N | IBRUTINIB | 101223115 |
| 10449222 | 10034086 | 0 | 76.8 | Curative (C) | 2019-01-06 | 2019-01-13 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100680513 |
| 10449239 | 10034087 | null | null | null | 2018-05-28 | 2018-05-28 | IBRUTINIB | 02 | null | IBRUTINIB | 100650479 |
| 10449253 | 10034088 | 1.62 | 87.2 | null | 2017-06-11 | 2017-06-19 | CAPECITABINE + OXALIPLATIN | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101824629 |
| 10449267 | 10034089 | 1.55 | 0 | Curative (C) | 2019-06-14 | 2019-06-14 | Rituximab | 02 | N | RITUXIMAB | 101051936 |
| 10449283 | 10034090 | 1.73 | 67 | Curative (C) | 2019-06-02 | 2019-06-08 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100690663 |
| 10449303 | 10034091 | 1.57 | null | Neo-adjuvant (N) | 2019-01-04 | 2019-01-06 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100583283 |
| 10449312 | 10034092 | 0 | 88 | null | 2021-05-15 | 2021-05-17 | IBRUTINIB | 02 | null | IBRUTINIB | 101368096 |
| 10449346 | 10034093 | 1.81 | 6.3 | null | 2022-01-01 | 2022-01-29 | Capecitabine | 02 | null | CAPECITABINE | 100069994 |
| 10449363 | 10034094 | null | 88.2 | 03 | 2016-08-14 | 2016-08-14 | Rituximab | 02 | N | RITUXIMAB | 100606036 |
| 10449383 | 10034095 | 1.69 | 59.8 | 03 | 2018-03-15 | 2018-03-15 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100792251 |
| 10449401 | 10034096 | 1.77 | 76.2 | null | null | 2021-08-27 | Docetaxel | 02 | null | DOCETAXEL | 101186019 |
| 10449407 | 10034097 | 1.77 | 65 | null | 2021-02-28 | 2021-03-12 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101133240 |
| 10449425 | 10034098 | 1.65 | 71 | Adjuvant (A) | 2018-03-15 | 2018-03-27 | Capecitabine | 02 | N | CAPECITABINE | 101712978 |
| 10449436 | 10034099 | 1.83 | 87.2 | Neo-adjuvant (N) | 2016-11-02 | 2016-12-01 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100416995 |
| 10449437 | 10034100 | 1.67 | 70.4 | 03 | 2018-08-07 | 2018-09-18 | Capecitabine | 02 | N | CAPECITABINE | 100098334 |
| 10449439 | 10034101 | 1.62 | 72.4 | null | 2021-09-08 | 2021-09-08 | Rituximab | 02 | null | RITUXIMAB | 100461759 |
| 10449483 | 10034102 | null | 107 | Palliative (P) | 2016-04-24 | 2016-05-12 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100346331 |
| 10449485 | 10034103 | 1.72 | 68.9 | Curative (C) | 2017-01-16 | 2017-01-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100286749 |
| 10449493 | 10034104 | 1.73 | 110.6 | 03 | 2016-11-10 | 2016-11-10 | Docetaxel | 02 | N | DOCETAXEL | 100618672 |
| 10449494 | 10034105 | 1.62 | 107.4 | Palliative (P) | 2019-08-30 | 2019-10-02 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101041474 |